Govt approves India-US MoU on infectious diseases including TB, HIV

10 March 2022 | News

MoU signed between Indian Council of Medical Research, India and the National Institute of Allergy and Infectious Diseases, US

image credit- shutterstock

image credit- shutterstock

The Union Cabinet, chaired by Prime Minister Narendra Modi, was apprised of a Memorandum of Understanding (MoU) signed between the Indian Council of Medical Research (ICMR) and the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health of Department of Health and Human Services, USA, in September 2021

Cooperation shall be undertaken primarily in Chennai, India at the National Institute for Research on Tuberculosis (NIRT) of ICMR in the scientific area, including but not limited to, basic, translational and applied innovative research, epidemiology, medicine, molecular biology, medical entomology, parasitology, immunology, medicine, microbiology and virology, with a focus on techniques for prevention, diagnosis and treatment of tropical infectious and allergic diseases.

Focus on collaboration includes tuberculosis, parasitic infections, HIV/AIDS, Allergic diseases, immune system diseases, other emerging and re-emerging pathogens, and other diseases of shared scientific interest.

The Parties may seek additional funding and active participation from governmental, non-governmental, private sector, foundation, and other sources, as necessary and consistent with usual and customary practice, to support individual projects.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account